11-019/ER+/PR+/HER2low 23 63 9; including TRODELVY 6 07-014/ER+/PR+/HER2low >18 62 9; including TRODELVY 5 Note that Trodelvy and Enhertu are antibody-drug conjugates recently approved for late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results